Thursday, December 27, 2012

Should Drug Companies Set More Limits?

Drug companies cashing in on human growth hormone abuse

Investigation shows record sales of human growth hormones

Gallery Image
Dr. Mark Molitch of Northwestern University, who helped write medical standards meant to limit HGH treatment to legitimate patients, holds an injector pen that contains approximately a weeks worth of doses for a patient in need of the drug. An Associated Press investigation shows that a federal crackdown on illicit foreign supplies of human growth hormone has failed to stop rampant misuse.

My opinion:
I understand how this container prevents the patient from accessing too much of the medication, but drug companies probably won't like this.  One of the biggest problems with "big pharma" is that it seems to sell medication that will obviously lead to dire consequences.  For example, drug companies could have made an alternative version of Sudafed that cannot be turned into meth, yet works just as well, if not better, than Sudafed at relieving symptoms.  Yet, since this cost more, the drug companies didn't make any changes, and the extraction of meth from Sudafed continued.  Should the government be cracking down on the drug companies, as well?  Also, I wonder if this is like the Prohibition, in some aspects.  After the Prohibition ended, and alcohol was once again legal, the amount of drinking actually decreased!  Do people tend to use steroids more when they are banned, too?   Feel free to comment.

No comments:

Post a Comment